The Department of Biotechnology (DBT) has floated National Biomedical Resource Indigenisation Consortium (N-BRIC) to drive focused indigenous innovation.
DBT constituted N-BRIC as a public-private-partnership to drive indigenous innovation especially in developing reagents, diagnostics, vaccines and therapeutics for Covid-19. The consortium will be based out of C-CAMP in Bengaluru and aims to provide a collaborative platform to build indigenous biomedical resources towards a self-reliant biotech ecosystem.
Renu Swarup, Secretary of DBT, said: “To meet our biotech and biomedical needs, the country needs to be self-reliant for product manufacturing and also the components, reagents, resources across the product development chain, N-BRIC brings together academia, industry, start-ups and MSME to serve not just the country but the world. To meet the Covid-19 challenges, this is a good start and we hope to enlarge this to include all required resources, platforms and facilities.”
Kiran Mazumdar-Shaw, Chairperson of N-BRIC, said: “This consortium is of immense national importance at a time of an unprecedented global health emergency. This will enable us to synergise and optimise the latent capabilities we possess across the pyramid of academic research labs, start-ups, MSMEs and large enterprise to deliver innovative solutions at scale for India and the world. I congratulate Renu Swarup for spearheading this vital initiative.”
“During these difficult times, we have realised the dire need of biomedical resources for healthcare system and research community. This consortium, a converging platform for all stake-holders, is a major effort by DBT, conceptualised by DBT Secretary Swarup, to address this need across country and promote indigenous development and manufacturing. This could be a massive paradigm shift towards fostering high-end research and innovation,” Taslimarif Saiyed, convener of N-BRIC, said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.